Ascendis Pharma (ASND) stock: 1,000% decade run, but pricey >15x P/S and unprofitable.
Ascendis: Why I'm Sceptical On Takeover Rumours, Long-Term Targets
Ascendis Pharma (ASND) stock: 1,000% decade run, but pricey >15x P/S and unprofitable.